Alzheimer's & Dementia
The latest scientific research and clinical treatment advances around Alzheimer's disease and dementia.
Random related stories from our 25-year archives
Researchers working with a remote population in the Amazon have found the group experiences extraordinarily low rates of dementia. The study follows on from prior findings that the same group displayed almost no cases of age-related heart disease.
Promising results from the very first primate trial looking at the brain-boosting effects of longevity protein klotho has buoyed scientists and opens the door to human trials aimed at restoring cognitive function and other age-related conditions.
Researchers have conducted the world’s first meta-analysis of the relationship between PTSD and dementia. Encompassing over a million subjects the study found PTSD can double a person’s risk of developing dementia in their senior years.
Deep brain stimulation (DBS) is a technique where wires are implanted into specific areas of the brain to deliver very mild electrical stimulation. A new study suggests the technique could be effective in improving behavioral and cognitive deficits in patients suffering from Alzheimer’s disease.
The fight against the debilitating effects of Alzheimer's and Parkinson's diseases may have just gotten a new weapon from an extract from the prickly pear cactus and brown seaweed known as peacock's tail – both which grow in abundance in the Mediterranean region.
A systematic review encompassing hundreds of studies has zeroed in on the 10 most common risk factors for Alzheimer’s disease. The researchers suggest avoiding these 10 factors could play a significant role in preventing the onset of Alzheimer’s.
Latest News
-
October 13, 2026 | Mike McRaeScientists have discovered a consistent anchor point on tau proteins where the molecules meet before contorting into a pathogenic shape. Blocking the site may substantially hinder the growth of the problematic protein tangles. -
September 15, 2026 | Mike McRaeAs the NFL season kicks off, a timely study has found that at least 18% of the 1,712 former NFL players who died between 2008 and 2021 had chronic traumatic encephalopathy when they died. But that number could be as high as 98.7%. -
September 03, 2026 | Mike McRaeA protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists thought, which could mean we may have to reconsider how we approach fighting this form of deadly neurodegeneration. -
August 31, 2026 | Mike McRaeNew findings by a team of researchers from the US and Australia have complicated an ongoing debate over whether a total joint arthroplasty may increase the risk of Alzheimer’s disease. -
August 30, 2026 | Mike McRaeDeveloped by researchers in the US, the remarkable new treatment could one day be used to treat patients in advanced stages of dementia by restoring the brain’s ability to recover from ongoing neurodegeneration. -
August 26, 2026 | Mike McRaeCognitive decline is far more common among individuals over the age of 65 years, but some genetic mutations cause the same characteristic loss of memory and mental processing in children. But the good news is that we now know how to treat it. -
August 23, 2026 | Bronwyn ThompsonIn a move that could drastically help slow the progression of Alzheimer's Disease (AD), the FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for patients as young as 40 years who have shown potential cognitive symptoms of the condition.